BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10445232)

  • 1. Further study on the effects of histamine H2 receptor agonist and antagonists on restraint-induced antinociception in mice.
    Wong JC
    Methods Find Exp Clin Pharmacol; 1999; 21(6):403-7. PubMed ID: 10445232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a histamine H2 receptor agonist and antagonist on restraint-induced antinociception in female mice.
    Wong CL
    Eur J Pharmacol; 1995 Jun; 279(2-3):109-13. PubMed ID: 7556390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The involvement of histamine H2-receptors in restraint-induced antinociception in male mice.
    Wong CL
    Methods Find Exp Clin Pharmacol; 1993; 15(6):351-6. PubMed ID: 7901462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two histamine H2 receptor antagonists, zolantidine and cimetidine, modulate nociception in cholestatic rats.
    Hasanein P
    J Psychopharmacol; 2011 Feb; 25(2):281-8. PubMed ID: 19825905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of morphine antinociception by centrally administered histamine H2 receptor antagonists.
    Hough LB; Nalwalk JW
    Eur J Pharmacol; 1992 Apr; 215(1):69-74. PubMed ID: 1355443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of 2-deoxy-D-glucose antinociception, but not hyperphagia by zolantidine, a histamine (H2) receptor antagonist.
    Koch JE; Hough LB; Bodnar RJ
    Pharmacol Biochem Behav; 1992 Feb; 41(2):371-6. PubMed ID: 1349437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antinociceptive, brain-penetrating derivatives related to improgan, a non-opioid analgesic.
    Hough LB; Nalwalk JW; Lu Q; Shan Z; Svokos K; Wentland MP; Montero MJ
    Eur J Pharmacol; 2005 Oct; 522(1-3):38-46. PubMed ID: 16216240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of histamine in naloxone-resistant and naloxone-sensitive models of swim stress-induced antinociception in the mouse.
    Oluyomi AO; Hart SL
    Neuropharmacology; 1991 Sep; 30(9):1021-7. PubMed ID: 1922693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of naltrexone and histamine antagonists on the antinociceptive activity of the cimetidine analog SKF92374 in rats.
    Li BY; Nalwalk JW; Hough LB
    Brain Res; 1997 Feb; 748(1-2):168-74. PubMed ID: 9067458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of histamine H2 receptors in restraint-morphine interactions.
    Nalwalk JW; Hough LB
    Life Sci; 1995; 57(13):PL153-8. PubMed ID: 7674814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of naloxone-resistant antinociception by centrally administered H2-antagonists.
    Gogas KR; Hough LB
    J Pharmacol Exp Ther; 1989 Jan; 248(1):262-7. PubMed ID: 2563290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of histamine H2 receptor agonists and antagonists on the isolated guinea pig gallbladder.
    Coruzzi G; Pozzoli C; Poli E; Coppelli G; Bertaccini G
    Fundam Clin Pharmacol; 1999; 13(1):84-90. PubMed ID: 10027092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of naloxone on restraint-induced antinociception in mice.
    Wong CL
    Methods Find Exp Clin Pharmacol; 1992 Nov; 14(9):695-700. PubMed ID: 1294857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study on the antinociceptive action of Tyr-K-MIF-1, a peptide from the MIF family.
    Zamfirova R; Bocheva A; Dobrinova Y; Todorov S
    Auton Autacoid Pharmacol; 2007 Apr; 27(2):93-8. PubMed ID: 17391278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of zolantidine a brain-penetrating H2-receptor antagonist, on naloxone-sensitive and naloxone-resistant analgesia.
    Gogas KR; Hough LB
    Neuropharmacology; 1988 Apr; 27(4):357-62. PubMed ID: 2901671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced antinociceptive effects of morphine in histamine H2 receptor gene knockout mice.
    Mobarakeh JI; Takahashi K; Sakurada S; Kuramasu A; Yanai K
    Neuropharmacology; 2006 Sep; 51(3):612-22. PubMed ID: 16806305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A role for histamine and H2-receptors in opioid antinociception.
    Gogas KR; Hough LB; Eberle NB; Lyon RA; Glick SD; Ward SJ; Young RC; Parsons ME
    J Pharmacol Exp Ther; 1989 Aug; 250(2):476-84. PubMed ID: 2547933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonistic action of naloxone on central histamine receptors-stimulated corticosterone secretion in rats under stress.
    Gadek-Michalska A; Bugajski J
    Agents Actions; 1989 Nov; 28(3-4):159-63. PubMed ID: 2531971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of histamine and related compounds on regional cerebral blood flow in rats.
    Suzuki G; Chen Z; Sugimoto Y; Fujii Y; Kamei C
    Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):613-7. PubMed ID: 10669907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The involvement of opioid delta receptor in restraint-induced antinociception in mice.
    Wong CL
    Methods Find Exp Clin Pharmacol; 1994 Jun; 16(5):309-13. PubMed ID: 7934309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.